Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schoeffter

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Pharmacology|December 1, 1984
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aortaR C Miller, M Mony, V Schini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1992
Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cellsH W Boddeke, A Fargin, J R Raymond, et al.
Biochemical Pharmacology|May 15, 1986
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aortaC Lugnier, P Schoeffter, A Le Bec, et al.
Journal of Medicinal Chemistry|January 6, 1995
(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinityJ Nozulak, H O Kalkman, P Floersheim, et al.
European Journal of Pharmacology|February 15, 1993
SDZ 216-525, a selective and potent 5-HT1A receptor antagonistP Schoeffter, J R Fozard, A Stoll, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1989
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtypeE Schlicker, K Fink, M Göthert, et al.
European Journal of Pharmacology|March 15, 1995
Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptorsP Schoeffter, J Pérez, D Langenegger, et al.
British Journal of Pharmacology|October 12, 1999
Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cellsL Gazi, I Bobirnac, M Danzeisen, et al.
Biochemical and Biophysical Research Communications|June 29, 1983
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activityC Lugnier, A Stierlé, A Beretz, et al.
European Journal of Pharmacology|March 15, 1995
Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptorsD Hoyer, J Pérez, P Schoeffter, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|December 1, 1984
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aortaR C Miller, M Mony, V Schini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1992
Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cellsH W Boddeke, A Fargin, J R Raymond, et al.
Biochemical Pharmacology|May 15, 1986
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aortaC Lugnier, P Schoeffter, A Le Bec, et al.
Journal of Medicinal Chemistry|January 6, 1995
(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinityJ Nozulak, H O Kalkman, P Floersheim, et al.
European Journal of Pharmacology|February 15, 1993
SDZ 216-525, a selective and potent 5-HT1A receptor antagonistP Schoeffter, J R Fozard, A Stoll, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1989
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtypeE Schlicker, K Fink, M Göthert, et al.
European Journal of Pharmacology|March 15, 1995
Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptorsP Schoeffter, J Pérez, D Langenegger, et al.
British Journal of Pharmacology|October 12, 1999
Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cellsL Gazi, I Bobirnac, M Danzeisen, et al.
Biochemical and Biophysical Research Communications|June 29, 1983
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activityC Lugnier, A Stierlé, A Beretz, et al.
European Journal of Pharmacology|March 15, 1995
Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptorsD Hoyer, J Pérez, P Schoeffter, et al.
Pageof 7